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potential way forward for a dual imaging approach in this youn-
ger age group.
doi:10.1016/j.ejcsup.2010.06.084
O-84 AN OBSERVER PERFORMANCE STUDY COMPARING THE
INTERPRETATION OF FULL-FIELD DIGITAL MAMMOGRAPHY
WITH DIGITAL BREAST TOMOSYNTHESIS
Rema K. Wasan, Asif Iqbal, David R. Evans, Clare Peacock, Juliet C.
Morel, Abdel Douiri, Michael J. Michell. King’s College Hospital,
UK. King’s College London, UK
Objective: The purpose of the current study was to compare the
diagnostic accuracy of two-view full-field digital mammography
(FFDM) with co-registered two-view digital breast tomosynthesis
(DBT).
Methods: The ethics committee approved trial evaluating a
Hologic Selenia Dimensions machine recruited women recalled
after their initial breast screening using analogue film-screen
mammography, scheduled to undergo further breast assessment
following informed consent. Radiologists fulfilling the profes-
sional criteria for National Health Service Breast Screening Pro-
gramme’s radiology practice reviewed all images using the Royal
College of Radiologists Breast Group classification for mammo-
graphic features 1–5 (M1 = normal, M2 = benign, M3 = probably
benign, M4 = suspicious, M5 = malignant).
Results: The study included bilateral mammograms of 526
women (age range 47–73 years) with 119 (22.6%) histologically
proven primary breast cancers assessed by 5 readers.
Using receiver operating characteristic (ROC) test, the analysis
yielded statistically significant difference (p = 0.0001) between
FFDM and DBT. The area under the ROC curve (AUC) was
0.968 ± 0.007 for DBT compared to AUC of 0.913 ± 0.015 for FFDM,
demonstrating DBT interpretation was superior.
Conclusion: Patients recalled after routine screening mammog-
raphy will benefit from DBT as an additional technique for diag-
nostic workup.
doi:10.1016/j.ejcsup.2010.06.085
O-85 WHAT DO CLINICIANS IN THE UK DO ONCE A PATIENT
HAS RECEIVED 5 YEARS OFADJUVANT HORMONAL AROMATASE
INHIBITOR (AI) CONTAINING TREATMENT?
Claire Gaunt, Daniel Rea. CRUK Clinical Trials Unit, University of
Birmingham, Birmingham, UK
Background: NICE guidelines advocate use of AIs within licence
for all but low risk patients. Early discharge at three years is also
recommended. To gauge interest in extended adjuvant endocrine
therapy research treatment practice and follow up practice needs
to be understood.
Methods: A survey designed to capture current practice for ER
positive, post-menopausal women who have completed 5 years
of treatment with an AI was distributed to 774 oncologists and
surgeons from 285 centres across the UK. The survey also cap-
tured opinion on a proposed trial of further treatment in this
patient group.
Results: A total of 159 clinicians (65 clinical oncologists; 28
medical oncologists; 63 surgeons and 3 others) responded to the
survey, representing 102 hospitals. The most common time for
routine discharge was 5 years regardless of nodal involvement
58% vs 12% before and 23% after 5 years. Patients with more than
4 nodes positive were discharged later than 5 years by 36%
respondents. The majority of respondents discontinue AIs at 5
years for node negative but continue AI use beyond 5 years in
node positive cases.
92% of responders expressed interest in participating in a clin-
ical trial of extended endocrine therapy most frequently selecting
node positive cases as the target population.
Conclusions: There is substantial variation in follow-up practice
and treatment for ER positive, post-menopausal women following
5 years of AI containing endocrine therapy within the UK. Many
clinicians would support a clinical trial of extended hormone
therapy in node positive patients.
doi:10.1016/j.ejcsup.2010.06.086
O-86 MASTECTOMY AND RECONSTRUCTION IN STAGE IV
BREAST CANCER: A SURVEY OF UK BREAST AND PLASTIC
SURGEONS
C.A.T. Durrant a, M. Khatib a, F.A. MacNeill b, S.E. James a, P.A.
Harris a. aDepartment of Plastic Surgery, Royal Marsden Hospital,
London, UK. bDepartment of Breast Surgery, Royal Marsden Hospital,
London, UK
Introduction: The number of women with stage IV disease who
have primary or delayed breast reconstruction is small. The pri-
mary aim of this study was to establish current UK practice and
opinions with regards to the appropriateness of breast recon-
struction in stage IV disease.
Methods: All 485 full members of the Association of Breast Sur-
geons (ABS) and all 378 full members of the British Association of
Plastic Reconstructive and Aesthetic Surgeons (BAPRAS) were
invited by email to take part in an online survey.
Results: Of the breast surgeons, 101 responded (26.9%). Of the
plastic surgeons 59 responded (16%). 78.9% would operate on
the primary tumour, mainly for local control. Plastic surgeons
showed a propensity for immediate reconstruction compared to
their breast surgery colleagues, and 26.6% of breast surgeons
would not offer reconstruction at all. Immediate latissimus dorsi
(LD) flap and implant was the favoured method in early stage dis-
ease (100%), with delayed LD and implant the most popular
option for stage IV disease (77.0%).
In patients who have already had a mastectomy, the majority
(54.4%) would offer reconstruction if stability of disease progres-
sion has been demonstrated.
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Conclusion: There is considerable variability of opinion, not
only between specialties, but also within specialties. As survival
figures continue to improve, the number of patients requesting
reconstruction is likely to increase. This will have an impact on
healthcare allocation and further debate will be necessary in
anticipation of future service development.
doi:10.1016/j.ejcsup.2010.06.087
O-87 RESEARCH OUTPUT OF CONSULTANT BREAST SURGEONS
IN THE UK AND IRELAND – A BIBLIOGRAPHIC ANALYSIS
R.W. Glynn, N.A. Healy, K.J. Sweeney, M.J. Kerin. Dept. of Surgery,
National University of Ireland, Galway, Ireland
The Research Assessment Exercise means that increasing
emphasis is placed on the evaluation of research output for fund-
ing and resource allocation. While the impact factor is widely
recognised as the key measure of journal quality, the h-index
has gained recognition as the most appropriate measure of an
individual’s productivity. The aim of this work is to describe the
bibliographic characteristics of consultant breast surgeons.
Breast-related output for 122 members of ABS at BASO was
identified using the Web of Science. A citation report for each sur-
geon was then created, providing the h-index, mean citations per
publication, and years of publication. A researcher has a h-index
of h if h of his/her publications have at least h citations each, and
the other publications (Np-h) have, at most, h citations each.
Articles (1176) were returned. The median articles published
per surgeon was 3 (IQR1-8); 26 returned 0 breast-related publica-
tions. Seventeen (14%) surgeons were responsible for 70%
(n = 825) of the output; 37 (30%) surgeons had published nothing
in the past decade. The range of h-index values for the cohort
was 0–50 with a median of 3 (IQR1–6). There was a positive corre-
lation between time since first publication and h-index (r = 0.599,
p = 0.000). The median number of citations per article, per sur-
geon, was 12 (IQR5–26).
A small minority are responsible for the majority of output,
with a large proportion contributing nothing, raising significant
questions for the future of scientific research.
doi:10.1016/j.ejcsup.2010.06.088
O-88 BREAST CANCER AMONG NIGERIAN WOMEN: CLINICAL
AND BIOLOGICAL DIFFERENCES COMPARED WITH AGE-MAT-
CHED UK WOMEN
J. Agboola a,b, A.A. Banjo b, N. Wanangwa a, S. El-Sheikh a, E.A.
Rakha a, E.C. Paish a, S. Watts a, D.G. Powea, I.O. Ellis a, A.R.
Green a. aDivision of Pathology, Nottingham University Hospitals and
University of Nottingham, UK. bDepartment of Morbid Anatomy and
Histopathology, Olabisi Onabanjo University and Olabisi Onabanjo
University Teaching Hospital, Sagamu, Nigeria
Background: Although, breast cancer incidence is lower in Afri-
can and African-American compared with Caucasian women
including White-Americans. However, Black women have a high
mortality rate compared with their Caucasian counterparts. Nige-
rian women have a higher risk for early-onset, high-grade, node-
positive disease with a high mortality rate from breast cancer.
Similar features have characterized hereditary and basal-like
breast cancer, prompting speculation that risk factors could be
genetically transmitted and the molecular portrait of these
tumours are different to those of Western women.
Methods: In this study, we assessed the clinico-pathological
and immunoprofile of breast cancer from Nigerian women com-
pared with age-matched UK control group using 9 biomarkers of
known relevance in breast cancer by immunohistochemistry.
Results: We confirm that Nigerian women presenting with
breast cancer are more frequently premenopausal and their
tumours are more of invasive ductal histological type and usually
larger size, higher grade, lymph node and vascular invasion posi-
tive compared with a UK age-match cohort. Nigerian breast can-
cer showed association with triple-negative and basal-like breast
cancer and are less frequently of luminal-like classes of tumours.
Univariate analysis showed association between breast cancer in
Nigerian women and ER, PgR, CK7/8 and E-cadherin negativity,
while having positive association with p53 and CK5/6 and 14,
but no association was found with HER2 expression. Nigerian
women showed poorer outcome after development of breast can-
cer compared with UK women.
Conclusion: This study demonstrates that there are genetic and
molecular differences between African and western women with
breast cancer which cannot be explained only by age. Breast can-
cer in Nigerian patients tends to be aggressive with a dismal out-
come. This might have implication for development of a
screening program and management of African breast cancer
patients.
doi:10.1016/j.ejcsup.2010.06.089
O-89 THE INFLUENCE OF CHILDHOOD ABUSE ON CLINICAL
RELATIONSHIPS IN BREAST CANCER: PERCEIVED PROFES-
SIONAL SUPPORT, CLINICIAN-RATED ‘DIFFICULTY’ AND INSE-
CURE ATTACHMENT
Louise Clark a, Chris Holcombe b, Helen Beesley b, Peter Salmon a.
aDivision of Clinical Psychology, University of Liverpool, UK. bRoyal
Liverpool University Hospital, UK
Background: Childhood abuse is a marker for insecure attach-
ment style which in turn is associated with an impaired ability
to seek and accept support. In healthcare, a history of childhood
abuse impaired breast cancer patients’ ability to obtain support
from clinical staff. The general aim of the current study was to
extend these findings and test whether breast cancer patients
recalling childhood abuse were experienced by consultant sur-
geons as more ‘difficult’ to help. The preliminary aim was to con-
firm that childhood abuse was associated with less perceived
professional support. The main study hypotheses were then (1)
childhood abuse would be associated with higher clinician-rated
‘difficulty’, and (2) insecure attachment would account for this
relationship.
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